Marico targets ₹20,000 cr by FY30, boosts Plix stake
In short
Marico raised its stake in Plix owner Satiya Nutraceuticals to 84.09% in a ₹1,012-crore deal. The company is aiming for ₹20,000 crore by FY30 and is backing that with digital-first growth and AI-led distribution.
This matters because it shows Marico is spending to push growth beyond its core business. The reporting does not say how fast the purchase will lift sales or profits.
What the reporting says
Marico raised its stake in Plix owner Satiya Nutraceuticals to 84.09% through a ₹1,012-crore acquisition as it pursues a ₹20,000 crore target by FY30. The reported move is tied to digital-first profitability, AI-led distribution and international diversification. What is not stated in the available reporting is how much of the FY30 goal will come from this acquisition or when the deal will fully affect earnings.
Why it matters
Marico raised its stake in Plix owner Satiya Nutraceuticals to 84.09% through a ₹1,012-crore acquisition while targeting ₹20,000 crore by FY30. The reported strategy focuses on digital-first profitability, AI-led distribution and international diversification. The immediate effect is a larger ownership position in a digital brand, but the reporting does not say how much the deal changes Marico’s earnings, margins or timeline.